Official websites use .gov
A
.gov
website belongs to an official government organization in the
United States.
Secure .gov websites use HTTPS
A
lock
(
) or
https://
means you’ve safely connected to the .gov website. Share sensitive
information only on official, secure websites.
PubMed ID:
19022547
Public Release Type:
Journal
Publication Year: 2009
Affiliation: Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA.
DOI:
https://doi.org/10.1053/j.ajkd.2008.08.010
Authors:
Pacheco-Silva A,
Markell M,
Alfrey E,
Bostom A,
Norman D,
Pesavento T,
Gallon L,
Bresnahan B,
Cosio F,
Vella J,
House A,
Yaqub MS,
Kasiske B,
Bolin P Jr,
Smith S,
Anil Kumar MS,
Bunnapradist M,
Singh A,
Fabrega A,
Conti D,
FAVORIT Study Investigators,
Koch M,
Pfeffer MA,
Mercier RY,
McKenney JL,
Levey AS,
Kusek JW,
Jacques PF,
Hunsicker L,
Carpenter MA,
Bostom AG,
Selhub J,
Pirsch J,
Cole E,
Matas A,
Ojo A,
Weir M,
Hunsicker L,
Danovitch G,
Adey D,
Kew C
Studies:
Folic Acid for Vascular Outcome Reduction in Transplantation Trial
Hyperhomocysteinemia may be a modifiable risk factor for the prevention of arteriosclerotic outcomes in patients with chronic kidney disease (CKD). Few clinical trials of homocysteine lowering have been conducted in persons with CKD before reaching end-stage renal disease. Kidney transplant recipients are considered individuals with CKD.
